The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patients

Abstract Background Adenosine signaling is now an accepted explanation for the therapeutic mechanism of Methotrexate (MTX) in rheumatoid arthritis (RA). Adenosine receptors categorized into four subclasses: adenosine A1 receptor (ADORA1), adenosine 2a receptor (ADORA2a), adenosine 2b receptor (ADORA...

Full description

Bibliographic Details
Main Authors: Nivine Fathi Darwish, Samar Abd Alhamed Tabra, Nivin Naeem Baiomy, Heba A. Mahmoud, Reham A. Mariah, Shymaa Ahmed Hablas
Format: Article
Language:English
Published: SpringerOpen 2022-02-01
Series:Egyptian Rheumatology and Rehabilitation
Subjects:
Online Access:https://doi.org/10.1186/s43166-021-00107-9
_version_ 1828135851495784448
author Nivine Fathi Darwish
Samar Abd Alhamed Tabra
Nivin Naeem Baiomy
Heba A. Mahmoud
Reham A. Mariah
Shymaa Ahmed Hablas
author_facet Nivine Fathi Darwish
Samar Abd Alhamed Tabra
Nivin Naeem Baiomy
Heba A. Mahmoud
Reham A. Mariah
Shymaa Ahmed Hablas
author_sort Nivine Fathi Darwish
collection DOAJ
description Abstract Background Adenosine signaling is now an accepted explanation for the therapeutic mechanism of Methotrexate (MTX) in rheumatoid arthritis (RA). Adenosine receptors categorized into four subclasses: adenosine A1 receptor (ADORA1), adenosine 2a receptor (ADORA2a), adenosine 2b receptor (ADORA2B), and adenosine 3 receptor (ADORA3). Our aim is to check the mRNA expression of two adenosine receptors; ADORA2a and ADORA3 in whole blood cell of RA patients and its relation in prediction of MTX clinical response in Egyptian patients. Results There was significant correlation between both ADORA2a and ADORA3 gene expression in RA patients as compared with healthy controls. The expression of ADORA2a and ADORA3 was increased in good and moderate response groups compared to no response group. There was significant correlation between both genes in mRNA expression before and after MTX treatment. Matrix metalloproteinase-3 (MMP3) concentration was significantly decreased after treatment in good and moderate response groups in comparison to non-responder group. Conclusion The inflammatory and clinical responses in RA patients which is demonstrated by DAS28 and suppression of MMP3 were regulated by ADORA2a and ADORA3. Their level of expression can predict MTX response and their agonists may offer a novel and effective therapeutic option for RA patients.
first_indexed 2024-04-11T17:53:53Z
format Article
id doaj.art-feaf10028f254607aab1f4c791bea807
institution Directory Open Access Journal
issn 1110-161X
2090-3235
language English
last_indexed 2024-04-11T17:53:53Z
publishDate 2022-02-01
publisher SpringerOpen
record_format Article
series Egyptian Rheumatology and Rehabilitation
spelling doaj.art-feaf10028f254607aab1f4c791bea8072022-12-22T04:10:58ZengSpringerOpenEgyptian Rheumatology and Rehabilitation1110-161X2090-32352022-02-014911910.1186/s43166-021-00107-9The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patientsNivine Fathi Darwish0Samar Abd Alhamed Tabra1Nivin Naeem Baiomy2Heba A. Mahmoud3Reham A. Mariah4Shymaa Ahmed Hablas5Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Tanta UniversityPhysical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Tanta UniversityDepartment of Clinical Pathology, Faculty of Medicine Tanta UniversityDepartment of Clinical Pathology, Faculty of Medicine Tanta UniversityDepartment of Clinical Pathology, Faculty of Medicine Tanta UniversityPhysical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Tanta UniversityAbstract Background Adenosine signaling is now an accepted explanation for the therapeutic mechanism of Methotrexate (MTX) in rheumatoid arthritis (RA). Adenosine receptors categorized into four subclasses: adenosine A1 receptor (ADORA1), adenosine 2a receptor (ADORA2a), adenosine 2b receptor (ADORA2B), and adenosine 3 receptor (ADORA3). Our aim is to check the mRNA expression of two adenosine receptors; ADORA2a and ADORA3 in whole blood cell of RA patients and its relation in prediction of MTX clinical response in Egyptian patients. Results There was significant correlation between both ADORA2a and ADORA3 gene expression in RA patients as compared with healthy controls. The expression of ADORA2a and ADORA3 was increased in good and moderate response groups compared to no response group. There was significant correlation between both genes in mRNA expression before and after MTX treatment. Matrix metalloproteinase-3 (MMP3) concentration was significantly decreased after treatment in good and moderate response groups in comparison to non-responder group. Conclusion The inflammatory and clinical responses in RA patients which is demonstrated by DAS28 and suppression of MMP3 were regulated by ADORA2a and ADORA3. Their level of expression can predict MTX response and their agonists may offer a novel and effective therapeutic option for RA patients.https://doi.org/10.1186/s43166-021-00107-9Adenosine receptorRheumatoid arthritisMTX responseInflammatory mediators
spellingShingle Nivine Fathi Darwish
Samar Abd Alhamed Tabra
Nivin Naeem Baiomy
Heba A. Mahmoud
Reham A. Mariah
Shymaa Ahmed Hablas
The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patients
Egyptian Rheumatology and Rehabilitation
Adenosine receptor
Rheumatoid arthritis
MTX response
Inflammatory mediators
title The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patients
title_full The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patients
title_fullStr The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patients
title_full_unstemmed The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patients
title_short The implication of adenosine receptor expression in prediction of methotrexate clinical response in Egyptian rheumatoid arthritis patients
title_sort implication of adenosine receptor expression in prediction of methotrexate clinical response in egyptian rheumatoid arthritis patients
topic Adenosine receptor
Rheumatoid arthritis
MTX response
Inflammatory mediators
url https://doi.org/10.1186/s43166-021-00107-9
work_keys_str_mv AT nivinefathidarwish theimplicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT samarabdalhamedtabra theimplicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT nivinnaeembaiomy theimplicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT hebaamahmoud theimplicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT rehamamariah theimplicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT shymaaahmedhablas theimplicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT nivinefathidarwish implicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT samarabdalhamedtabra implicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT nivinnaeembaiomy implicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT hebaamahmoud implicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT rehamamariah implicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients
AT shymaaahmedhablas implicationofadenosinereceptorexpressioninpredictionofmethotrexateclinicalresponseinegyptianrheumatoidarthritispatients